2 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
of SGLT2 inhibitors ... in CVD and CKD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #inhibitors #EBM
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... Stages #ACCAHA #Algorithm ... #Management #Cardiology